Filter
269
Text search:
Licensed
pharmaceutical
products
Featured
Recommendations
15
New Publications
65
Language
Document type
No document type
112
Studies & Reports
72
Guidelines
42
Manuals
23
Strategic & Response Plan
14
Fact sheets
4
Situation Updates
2
Countries / Regions
Kenya
24
Nigeria
9
South Africa
9
Liberia
7
Ghana
7
Uganda
7
Zimbabwe
7
India
7
Ethiopia
6
Sierra Leone
5
Tanzania
5
Bangladesh
5
Western and Central Europe
5
Philippines
4
Zambia
4
Malawi
4
Botswana
4
Global
4
Senegal
3
Nepal
3
Syria
3
Rwanda
3
Ukraine
3
Eastern Europe and Central Asia
3
Cambodia
2
Indonesia
2
Benin
2
Namibia
2
Eswatini/ Swaziland
2
Myanmar / Burma
2
Latin America and the Carribbean
2
United Kingdom
2
Burkina Faso
1
Cameroon
1
Haiti
1
Thailand
1
Sudan
1
Brazil
1
Lesotho
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Asia
1
Africa
1
Eastern Europe
1
Moldova
1
North America
1
Gabon
1
Authors & Publishers
Publication Years
Category
Countries
140
Clinical Guidelines
16
Pharmacy & Technologies
11
Public Health
10
Key Resources
6
Women & Child Health
5
Capacity Building
1
Toolboxes
Pharmacy
49
AMR
48
COVID-19
19
Mental Health
8
TB
7
HIV
5
Ebola
3
Conflict
3
Caregiver
3
NTDs
3
Global Health Education
2
Planetary Health
2
Disability
1
Natural Hazards
1
Rapid Response
1
Refugee
1
Health Financing Toolbox
1
NCDs
1
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people
...
This guide is available in English, French, Spanish, Russian, Arabic and Chinese
This guide consolidates COVID-19 guidance for human resources for health managers and policy-makers at national, subnational and facility levels to design, manage and preserve the workforce necessary to manage the COVI
...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a
...
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we
...
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Expanding access to quality health services through task sharing
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initiative was to improve reporting of adverse events (A
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
A practical guide for hospital administrators, health disaster coordinators, health facility designers, engineers and maintenance staff to achieve Smart Health Facilities by conserving resources, cutting costs, increasing efficiency in operations and reducing carbon emissions
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
The overall goal of the programme, to reduce the malaria morbidity and mortality by 75% (using 2012 as baseline) by the year 2020, continued to be pursued in 2014. The following areas were identified as some of the priorities for the year: Malaria Case Management under which we have Malaria in Pregn
...
